Quarterly Report I 19/20

September 2019 – November 2019, Diamyd Medical AB (publ), Fiscal year 2019/2020Developing therapies for type 1 diabetesDiamyd Medical’s B-share is traded on Nasdaq First North Growth Market under the ticker DMYD B.Further information is available on https://www.diamyd.com Figures in parentheses relate to the corresponding period previous financial year. September 1, 2019 – November 30, 2019 · Net income: MSEK 0.1 (0.3) · Net result: MSEK -6.8 (-8.5) · Result per share: SEK -0.1 (-0.2) · Cash flow from operating activities: MSEK -6.1 (-10.8) · Liquid assets and